Avecho Biotechnology Limited (ASX:AVE)
Australia · Delayed Price · Currency is AUD 0.0220
+0.0010 (4.76%)
Sep 11, 2026, 12:09 PM AEST
Avecho Biotechnology Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.66 | -4.42 | -3.12 | -3.44 | -2.34 | -3.42 |
Depreciation & Amortization | 0.12 | 0.14 | 0.14 | 0.18 | 0.23 | 0.43 |
Stock-Based Compensation | 0.39 | 0.39 | 0.01 | 0.1 | 0.2 | 0.53 |
Provision & Write-off of Bad Debts | - | - | - | -0 | -0.02 | 0.05 |
Other Operating Activities | -5.37 | 0.06 | 0.05 | 0.37 | - | - |
Change in Accounts Receivable | 0.04 | 0.04 | -1.15 | -0.35 | 0.4 | -0.67 |
Change in Inventory | 0.13 | 0.13 | -0.04 | -0.06 | -0.21 | -0.1 |
Change in Accounts Payable | -0.01 | -0.01 | 0.03 | -0.09 | 0.03 | 0.03 |
Change in Unearned Revenue | 4.83 | 4.83 | -0.16 | 0.16 | - | - |
Change in Other Net Operating Assets | -0.07 | -0.07 | 0.26 | -0.04 | 0.04 | 0.04 |
Operating Cash Flow | -3.59 | 1.1 | -3.97 | -3.18 | -1.67 | -3.1 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | - | - | - | -0.05 | -0.2 |
Other Investing Activities | - | - | -0.02 | - | - | - |
Investing Cash Flow | -0 | - | -0.02 | - | -0.05 | -0.2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 0.93 | - | - | - |
Long-Term Debt Repaid | - | -1.13 | -0.08 | -0.07 | -0.08 | -0.07 |
Lease Payments | -0.08 | -0.08 | -0.08 | -0.07 | -0.08 | -0.07 |
Net Debt Issued (Repaid) | -0.13 | -1.13 | 0.85 | -0.07 | -0.08 | -0.07 |
Issuance of Common Stock | 4.6 | 2.5 | - | 8 | 0 | 5.06 |
Other Financing Activities | -0.21 | -0.19 | - | -0.72 | - | -0.29 |
Financing Cash Flow | 4.27 | 1.19 | 0.85 | 7.22 | -0.08 | 4.69 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.68 | 2.29 | -3.13 | 4.04 | -1.8 | 1.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.59 | 1.1 | -3.97 | -3.18 | -1.72 | -3.3 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -487.21% | 89.12% | -350.38% | -671.51% | -152.16% | -416.01% |
Free Cash Flow Per Share | -0.00 | - | -0.00 | -0.00 | -0.00 | -0.00 |
Levered Free Cash Flow | -2.27 | -2.14 | -2.85 | -1.89 | -0.86 | -1.99 |
Unlevered Free Cash Flow | -1.99 | -1.85 | -2.81 | -1.88 | -0.86 | -1.99 |
Free Cash Flow After Leases | -3.68 | 1.02 | -4.05 | -3.25 | -1.8 | -3.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0.01 | 0.01 | 0 | 0.01 |
Cash Income Tax Paid | - | -1.7 | -1.07 | -0.72 | -1.04 | - |
Change in Working Capital | 4.92 | 4.92 | -1.05 | -0.39 | 0.27 | -0.69 |